MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Symptomatic delayed-onset edema following deep brain stimulation for Parkinson’s disease: occurrence, symptoms, management and outcomes. Experience of a single center.

    B. Minafra, NG. Pozzi, M. Picascia, R. Zangaglia, F. Bruschi, F. Avantaggiato, M. Todisco, D. Servello, C. Pacchetti (Pavia, Italy)

    Objective: To report on occurrence, symptoms, management and outcomes of SDE following DBS of either the subthalamic nucleus (STN) or Globus pallidum interna nucleus (GPi)…
  • 2019 International Congress

    Apraxia of Eye Lid Opening in patients with advanced Parkinson’s disease undergoing subthalamic stimulation – a single-centre experience.

    K. Shetty, S. Krishan, K. Kesavapisharady, D. Puthenveedu, A. Kishore (Thiruvananthapuram, India)

    Objective: We aimed to assess the cumulative incidence of apraxia of eye lid opening (AOELO) in patients who have undergone bilateral subthalamic nucleus deep brain…
  • 2019 International Congress

    Late onset idiopathic cerebral edema associated with deep brain stimulation

    M. Blázquez Estrada, P. Siso García, E. Suárez Sanmartín, J. Sol Alvarez, E. Santamarta Liébana, C. García Fernández, B. Lozano Aragoneses, J. Alvarez Carriles, A. Sáiz Ayala (Oviedo, Spain)

    Objective: To present two case report Background: Deep brain stimulation (DBS) is an effective surgical therapy for certain neurological and psychiatric disorders, but it is…
  • 2019 International Congress

    Protective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via modulating mitochondrial dynamics

    W. Jang, JY. Ahn (Gangneung, Republic of Korea)

    Objective: The present study elucidated the neuroprotective effects of tDCS on the mitochondrial quality control pathway in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. Background: Abnormal…
  • 2019 International Congress

    Jane Avril: Toulouse-Lautrec’s favourite courtisan and Moulin Rouge’s choreic dancer

    F. Germiniani, C. Camargo, G. Franklin, G. Ribas, L. Pinheiro, P. Marques, H. Teive (Curitiba, Brazil)

    Objective: Our aim is to analyse selected portraits of Jane Avril, Moulin Rouge's most famous dancer, done by Toulouse-Lautrec, in which some features of chorea…
  • 2019 International Congress

    TUBB4A mutation: Expansion of H-ABC phenotype with apparent iron accumulation in the basal ganglia – case report and literature review

    C. Gorodetsky, I. Tein (Toronto, ON, Canada)

    Objective: This case report expand the phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum. Background: Background: Hypomyelination with atrophy of the basal ganglia…
  • 2019 International Congress

    Exposed-Only Analysis of Gene-Pesticide Interaction in Parkinson’s Disease (PD)

    J. Kaye, L. Lima, C. Tanner, S. Finkbeiner, R. Swanson, S. Goldman (San Francisco, CA, USA)

    Objective: Assess gene-pesticide associations with PD using an exposed-only design in a highly exposed cohort. Background: Pesticide use is associated with an increased risk of…
  • 2019 International Congress

    Actigraphically Characterized Infradian Rest-Activity Rhythms in Parkinson’s Disease

    C. Brooks, R. Koehler, MK. Erb, F. Mortazavi, J. Bhangu, K. Thomas (Boston, MA, USA)

    Objective: To characterize infradian variations across the week in participants with Parkinson’s disease (PD), preliminary analyses were conducted as a means to develop a process…
  • 2019 International Congress

    Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease

    H. Dafsari, S. Jost, A. Sauerbier, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, P. Löhrer, A. Rizos, JN. Petry-Schmelzer, G. Fink, M. Barbe, A. Antonini, P. Martinez-Martin, K. Ray-Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of sleep, depression, and quality of life (QoL) compared…
  • 2019 International Congress

    Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

    J. Gonzalez (Lima, Peru)

    Objective: To compare the presence of autonomic symptoms on Parkinson's disease (PD) and essential tremor (ET) applying the Scale for Outcomes in Parkinson’s disease for…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley